Yayın: Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study
Yükleniyor...
Tarih
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayımcı
Özet
Açıklama
Anahtar kelimeler
Alectinib, Medicine, Oncology, Internal medicine, Lung cancer, Stage (stratigraphy), Progression-free survival, Ceritinib, Chemotherapy, Crizotinib